Click for best price
Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share 2023
| Market size in 2022 |
US$ 1027.7 million
|
Forecast Market size by 2029 |
US$ 2031 million
|
| Growth Rate |
CAGR of 10.2% |
Number of Pages |
69 Pages |
This report aims to provide a comprehensive presentation of the global market for Cancer Immunotherapy Drug Discovery Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Immunotherapy Drug Discovery Outsourcing. This report contains market size and forecasts of Cancer Immunotherapy Drug Discovery Outsourcing in global, including the following market information:
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Immunotherapy Drug Discovery Outsourcing market was valued at US$ 1027.7 million in 2022 and is projected to reach US$ 2031 million by 2029, at a CAGR of 10.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Drug Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Immunotherapy Drug Discovery Outsourcing include Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd, Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co. and Horizon Discovery Group PLC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Immunotherapy Drug Discovery Outsourcing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, by Type, 2022 (%)
By Drug Type
By Cancer Type
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, by Application, 2022 (%)
Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Immunotherapy Drug Discovery Outsourcing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Immunotherapy Drug Discovery Outsourcing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Immunotherapy Drug Discovery Outsourcing, market overview.
Chapter 2: Global Cancer Immunotherapy Drug Discovery Outsourcing market size in revenue.
Chapter 3: Detailed analysis of Cancer Immunotherapy Drug Discovery Outsourcing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Immunotherapy Drug Discovery Outsourcing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Immunotherapy Drug Discovery Outsourcing Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 1027.7 million
|
| Forecast Market size by 2029 |
US$ 2031 million
|
| Growth Rate |
CAGR of 10.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Immunotherapy Drug Discovery Outsourcing Overall Market Size
2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size: 2022 VS 2032
2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Immunotherapy Drug Discovery Outsourcing Players in Global Market
3.2 Top Global Cancer Immunotherapy Drug Discovery Outsourcing Companies Ranked by Revenue
3.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Immunotherapy Drug Discovery Outsourcing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Immunotherapy Drug Discovery Outsourcing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Immunotherapy Drug Discovery Outsourcing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Immunotherapy Drug Discovery Outsourcing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Immunotherapy Drug Discovery Outsourcing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Markets, 2022 & 2032
By Drug Type
By Cancer Type
4.2 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue & Forecasts
4.2.1 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2023
4.2.2 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2024-2032
4.2.3 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2022 & 2032
5.1.2 Lung
5.1.3 Breast
5.1.4 Colorectal
5.1.5 Melanoma
5.1.6 Prostate
5.1.7 Head and Neck
5.1.8 Ovarian
5.1.9 Pancreatic
5.2 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue & Forecasts
5.2.1 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2023
5.2.2 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2024-2032
5.2.3 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2022 & 2032
6.2 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue & Forecasts
6.2.1 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2023
6.2.2 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2024-2032
6.2.3 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2032
6.3.2 US Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.3.3 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.3.4 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2032
6.4.2 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.4.3 France Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.4.4 U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.4.5 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.4.6 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.4.7 Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.4.8 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2032
6.5.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.5.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.5.4 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.5.5 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.5.6 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2032
6.6.2 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.6.3 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2032
6.7.2 Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.7.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.7.4 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
6.7.5 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2032
7 Cancer Immunotherapy Drug Discovery Outsourcing Companies Profiles
7.1 Aquila BioMedical
7.1.1 Aquila BioMedical Company Summary
7.1.2 Aquila BioMedical Business Overview
7.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.1.4 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.1.5 Aquila BioMedical Key News & Latest Developments
7.2 BPS Bioscience, Inc.
7.2.1 BPS Bioscience, Inc. Company Summary
7.2.2 BPS Bioscience, Inc. Business Overview
7.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.2.4 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.2.5 BPS Bioscience, Inc. Key News & Latest Developments
7.3 Celentyx Ltd
7.3.1 Celentyx Ltd Company Summary
7.3.2 Celentyx Ltd Business Overview
7.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.3.4 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.3.5 Celentyx Ltd Key News & Latest Developments
7.4 Crown Bioscience, Inc.
7.4.1 Crown Bioscience, Inc. Company Summary
7.4.2 Crown Bioscience, Inc. Business Overview
7.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.4.4 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.4.5 Crown Bioscience, Inc. Key News & Latest Developments
7.5 DiscoverX Corporation
7.5.1 DiscoverX Corporation Company Summary
7.5.2 DiscoverX Corporation Business Overview
7.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.5.4 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.5.5 DiscoverX Corporation Key News & Latest Developments
7.6 Explicyte
7.6.1 Explicyte Company Summary
7.6.2 Explicyte Business Overview
7.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.6.4 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.6.5 Explicyte Key News & Latest Developments
7.7 Genscript Biotech Corporation
7.7.1 Genscript Biotech Corporation Company Summary
7.7.2 Genscript Biotech Corporation Business Overview
7.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.7.4 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.7.5 Genscript Biotech Corporation Key News & Latest Developments
7.8 HD Biosciences Co.
7.8.1 HD Biosciences Co. Company Summary
7.8.2 HD Biosciences Co. Business Overview
7.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.8.4 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.8.5 HD Biosciences Co. Key News & Latest Developments
7.9 Horizon Discovery Group PLC
7.9.1 Horizon Discovery Group PLC Company Summary
7.9.2 Horizon Discovery Group PLC Business Overview
7.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.9.4 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.9.5 Horizon Discovery Group PLC Key News & Latest Developments
7.10 ImmunXperts SA
7.10.1 ImmunXperts SA Company Summary
7.10.2 ImmunXperts SA Business Overview
7.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.10.4 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.10.5 ImmunXperts SA Key News & Latest Developments
7.11 Molecular Imaging, Inc.
7.11.1 Molecular Imaging, Inc. Company Summary
7.11.2 Molecular Imaging, Inc. Business Overview
7.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.11.4 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.11.5 Molecular Imaging, Inc. Key News & Latest Developments
7.12 Promega Corporation,Personalis, Inc.
7.12.1 Promega Corporation,Personalis, Inc. Company Summary
7.12.2 Promega Corporation,Personalis, Inc. Business Overview
7.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.12.4 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.12.5 Promega Corporation,Personalis, Inc. Key News & Latest Developments
7.13 STC Biologics
7.13.1 STC Biologics Company Summary
7.13.2 STC Biologics Business Overview
7.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.13.4 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2018-2023)
7.13.5 STC Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunities & Trends in Global Market
Table 2. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers in Global Market
Table 3. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints in Global Market
Table 4. Key Players of Cancer Immunotherapy Drug Discovery Outsourcing in Global Market
Table 5. Top Cancer Immunotherapy Drug Discovery Outsourcing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Immunotherapy Drug Discovery Outsourcing Product Type
Table 9. List of Global Tier 1 Cancer Immunotherapy Drug Discovery Outsourcing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Immunotherapy Drug Discovery Outsourcing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2024-2032
Table 30. Aquila BioMedical Company Summary
Table 31. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 32. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 33. Aquila BioMedical Key News & Latest Developments
Table 34. BPS Bioscience, Inc. Company Summary
Table 35. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 36. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 37. BPS Bioscience, Inc. Key News & Latest Developments
Table 38. Celentyx Ltd Company Summary
Table 39. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 40. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 41. Celentyx Ltd Key News & Latest Developments
Table 42. Crown Bioscience, Inc. Company Summary
Table 43. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 44. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 45. Crown Bioscience, Inc. Key News & Latest Developments
Table 46. DiscoverX Corporation Company Summary
Table 47. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 48. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 49. DiscoverX Corporation Key News & Latest Developments
Table 50. Explicyte Company Summary
Table 51. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 52. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 53. Explicyte Key News & Latest Developments
Table 54. Genscript Biotech Corporation Company Summary
Table 55. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 56. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 57. Genscript Biotech Corporation Key News & Latest Developments
Table 58. HD Biosciences Co. Company Summary
Table 59. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 60. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 61. HD Biosciences Co. Key News & Latest Developments
Table 62. Horizon Discovery Group PLC Company Summary
Table 63. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 64. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 65. Horizon Discovery Group PLC Key News & Latest Developments
Table 66. ImmunXperts SA Company Summary
Table 67. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 68. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 69. ImmunXperts SA Key News & Latest Developments
Table 70. Molecular Imaging, Inc. Company Summary
Table 71. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 72. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 73. Molecular Imaging, Inc. Key News & Latest Developments
Table 74. Promega Corporation,Personalis, Inc. Company Summary
Table 75. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 76. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 77. Promega Corporation,Personalis, Inc. Key News & Latest Developments
Table 78. STC Biologics Company Summary
Table 79. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 80. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn) & (2018-2023)
Table 81. STC Biologics Key News & Latest Developments
List of Figures
Figure 1. Cancer Immunotherapy Drug Discovery Outsourcing Segment by Type in 2022
Figure 2. Cancer Immunotherapy Drug Discovery Outsourcing Segment by Application in 2022
Figure 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2022
Figure 8. By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 9. By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 10. By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 12. By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 14. By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 15. By Country - North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 16. US Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 20. Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 21. France Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 28. China Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 32. India Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 34. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2018-2032
Figure 37. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2018-2032
Figure 41. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
